These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Side effects and complications in lithium therapy. Svestka J; Náhunek K; Rodová A Act Nerv Super (Praha); 1970; 12(3):264-5. PubMed ID: 5457452 [No Abstract] [Full Text] [Related]
7. [Adverse effects of lithium carbonate used for the prevention of recurrent affective disorders]. Kiljan A; Pietruszewska I Psychiatr Pol; 1980; 14(4):343-50. PubMed ID: 7443883 [No Abstract] [Full Text] [Related]
8. [Lithium therapy in the prevention of cyclothymic psychoses]. Lenz H; Pürgyi P Wien Med Wochenschr; 1971 Jun; 121(25):522-4. PubMed ID: 5129948 [No Abstract] [Full Text] [Related]
9. [Lithium salts and sodium chloride. Lithium in the therapy of psychoses and its possible damaging effects]. Messini M; Messini P Clin Ter; 1971 Nov; 59(4):291-319. PubMed ID: 4947174 [No Abstract] [Full Text] [Related]
10. The use of sustained release lithium carbonate in general practice. A pilot study. Salkind MR J R Coll Gen Pract; 1970 Jul; 20(96):13-21. PubMed ID: 4920254 [No Abstract] [Full Text] [Related]
11. Current situation of long-term treatment of depression. Vallejo Ruiloba J Actas Esp Psiquiatr; 2007; 35(5):285-99. PubMed ID: 17885821 [TBL] [Abstract][Full Text] [Related]
12. SAMe for depression. Med Lett Drugs Ther; 1999 Nov; 41(1065):107-8. PubMed ID: 10575417 [No Abstract] [Full Text] [Related]
13. [Treatment of depression with chlorimipramine. Review of literature and personal clinical experiences]. Rossner M; Ficker F Psychiatr Neurol Med Psychol (Leipz); 1972 Jul; 24(7):369-83. PubMed ID: 4562548 [No Abstract] [Full Text] [Related]
14. Quetiapine augmentation of treatment-resistant depression: a comparison with lithium. Dorée JP; Des Rosiers J; Lew V; Gendron A; Elie R; Stip E; Tourjman SV Curr Med Res Opin; 2007 Feb; 23(2):333-41. PubMed ID: 17288688 [TBL] [Abstract][Full Text] [Related]
15. Lithium augmentation therapy in refractory depression-update 2002. Bauer M; Forsthoff A; Baethge C; Adli M; Berghöfer A; Döpfmer S; Bschor T Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):132-9. PubMed ID: 12904977 [TBL] [Abstract][Full Text] [Related]
16. How long should prophylactics be continued in affective disorders? Freyhan FA Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):137-41. PubMed ID: 981328 [TBL] [Abstract][Full Text] [Related]
17. [Thyroid function in long-term use of lithium salts for prevention of recurrence of affective disorders]. Wasilewski B Psychiatr Pol; 1982; 16(3):113-9. PubMed ID: 6817355 [No Abstract] [Full Text] [Related]
18. [First results of symptom statistical studies on the characterization of the clinical effect profile of the antidepressive agent noxiptilin]. Bente D; Engelmeier MP; Heinrich K; Hippius H; Schmitt W Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:889+. PubMed ID: 5819770 [No Abstract] [Full Text] [Related]
19. [Comparison between 2 preparations forms: slide-effects of prophylactic lithium therapy]. Laurell B; Persson G Lakartidningen; 1970 Jul; 67(27):3083-5. PubMed ID: 4918342 [No Abstract] [Full Text] [Related]
20. [Prophylactic use of lithium carbonate in manic-depressive psychosis (results of therapy and methods of assessment)]. Mikhalenko IN; Nuller IuL Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(5):752-7. PubMed ID: 5122141 [No Abstract] [Full Text] [Related] [Next] [New Search]